| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.032 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |